PATENT CLAIM ANALYSIS

Application Number: 15966533
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["424", "130100"]

Abstract:
Isolated human monoclonal antibodies which bind to IL-8 (e.g., human IL-8) are disclosed. The human antibodies can be produced in a hybridoma, transfectoma or in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals, hybridomas, and transfectomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.

Claim (Index 3):
The antibody of  claim 2 , wherein the antibody is an IgG1 antibody.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 91.0
- Lexical Diversity: 1.72222
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15138490', '10738120', '13337798', '11823481', '12616615']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8618024935119005
- 35 USC 102 Novelty (BERT): 0.6396571551110851
- Combined Prediction Score: 0.839587959671819
- Mean Citation Score: 598.240986
- Max Citation Score: 610.9736
- Similarity Product: 584.9630731069565

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test